• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NF-κB as a therapeutic target in inflammatory bowel disease

Research Project

Project/Area Number 14570493
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

NAITO Yuji  Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Assistant Professor, 医学研究科, 助手 (00305575)

Co-Investigator(Kenkyū-buntansha) YOSHIKAWA Toshikazu  Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Professor, 医学研究科, 教授 (90158410)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2003: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2002: ¥700,000 (Direct Cost: ¥700,000)
Keywordsulcerative colitis / experimental model of colitis / transcriptional factor / molecular target therapy / inflammatory cytokines / spin trapping agent / pioglitazone / gene expression regulation / 炎症性腸疾患 / NF-κB / PPAR / 核内受容体
Research Abstract

Using a model of dextran sulfate sodium (DSS)-induced colitis in mice, we have demonstrated the following findings; 1)the activity of NF-kB determined by EMSA assay was enhanced in the course of colitis; 2)the gene expression of NE-kB-related genes such as inducible NO synthase and pro-inflammatory cytokines was upregulated related with NF-kB activation; 3)the activation of NF-kB correlated with the development intestinal inflammation and clinical index of colitis; 4)the inhibitors of NF-kB activation (spin trappin agent PBN, PPAR-g ligand pioglitazone, antioxidant vitamin E derivative) demonstrate the inhibition of DSS-induced colitis ; and 5)NF-kB activation and intestinal inflammation was enhanced in tumor necrosis factor-deficient mice. These results indicate that NF-kB-dependent gene transcription plays a critical role in the pathogenesis of DSS-induced colitis in mice.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Naito Y, Takagi T, Ishikawa T, et al.: "alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice"Antioxid Redox Signal. 4. 195-206 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takagi T, Naito Y, Tomatsuri N, et al.: "Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade"Redox Rep. 7. 283-289 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Naito Y, Takagi T, Uchiyama K, et al.: "Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats"Redox Rep. 7. 294-299 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Naito Y, Takagi T, Handa O, et al.: "Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice"J Gastroenterol Hepatol. 18. 560-569 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 内藤裕二, 吉川敏一: "炎症性腸疾患とNO-誘導型一酸化窒素合成酵素は治療標的分子となりうるか"医学のあゆみ. 204. 641-645 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T, Kotake Y.: "alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice."Antioxid Redox Signal. 4. 495-206 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takagi T, Naito Y, Tomatsuri N, Handa O, Ichikawa H, Yoshida N, Yoshikawa T.: "Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade."Redox Rep. 7. 283-289 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Naito Y, Takagi T, Uchiyama K, Handa O, Tomatsuri N, Imamoto E, Kokura S, Ichikawa H, Yoshida N, Yoshikawa T.: "Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats."Redox Rep. 7. 294-299 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T.: "Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice."J Gastroenterol Hepatol. 18. 560-569 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Naito Y, Takagi T, Ishikawa T, et al.: "alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice"Antioxid Redox Signal. 4. 195-206 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takagi T, Naito Y, Tomatsuri N, et al.: "Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade"Redox Rep. 7. 283-289 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Naito Y, Takagi T, Uchiyama K, et al.: "Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats"Redox Rep. 7. 294-299 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Naito Y, Takagi T, Handa O, et al.: "Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice"J Gastroenterol Hepatol. 18. 560-569 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 内藤裕二, 吉川敏一: "炎症性腸疾患とNO-誘導型一酸化窒素合成酵素は治療標的分子となりうるか"医学のあゆみ. 204. 641-645 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Naito Y, Takagi T, et al.: "α-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice"Antioxidants & Redox Signaling. 4. 195-206 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takagi T, Naito Y, et al.: "Pioglitazone, a PPAR-γ ligand, provides protection from dextran sulfate sodium-induced colitis in mice"Redox Report. 7. 283-289 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Naito Y, Takagi T et al.: "Enhanced intestinal intlammation induced by dextran sulfate sodium in tumor necrosis taetor-α-deficient mice"J. Gastroenterol Hepatol. (in press). (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi